Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 110-114

  Shetty, Bhasker V ^a   Kosa, Maha B ^a   Khalil, Deborah A ^a   Webber, Stephanie ^a  

^a AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAVENOUS DRUG ADMINISTRATION; MALE; MARMOSET; MESENTERY LYMPH NODE; MONKEY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPLEEN;

EID: 0030032764     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.110     Document Type: Article

References (14)

1. Appelt, K., R. J. Bacquet, C. Bartlett, C. L. J. Booth, S. T. Freer, M. M. Fuhry, M. R. Gehring, S. M. Herrmann, E. F. Howland, C. A. Janson, T. R. Jones, C. C. Kan, V. Kathardekar, K. K. Lewis, G. P. Marzoni, D. A. Mathews, C. Mohr, E. W. Moomaw, C. A. Morse, S. J. Oatley, R. C. Ogden, M. R. Reddy, S. H. Reich, W. S. Schoettlin, W. W. Smith, M. D. Varney, J. E. Villafranca, R. W. Ward, S. Webber, S. E. Webber, K. M. Welsh, and J. White. 1991. Design of enzyme inhibitors using iterative protein crystallographic analysis. J. Med. Chem. 34:1925-1928
2. Condra, J. H., W. A. Schleif, O. M. Blahy, L. J. Gabryelski, D. J. Graham, J. C. Quintero, A. Rhodes, H. L. Robbins, E. Roth, M. Shivaprakash, P. L. Titus, T. Yang, and E. A. Emini. 1995. Mutations in HIV protease conferring resistance to inhibitor L-735,524, abstr. 187, p. 88. In Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections
3. Debouck, C., and B. W. Metcalf. 1990. Human immunodeficiency virus protease. target for AIDS therapy. Drug Dev. Res. 21:1-17.
4. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York
5. Ho, D., A. V. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid Turnover of plasma virons and CD4 lymphocytes in HIV-1 infection Nature (London) 373:123-126.
6. Markowitz, M., L. Jalil, A. Hurley, C. Farthing, Y. Cao, M. S. Saag, W. Powderly, J. Valdes, J. Leonard, and D. D. Ho. 1995. Evaluation of the antiviral activity of orally administered ABT-538, an inhibitor of HIV-1 protease, abstr. 185, p 88 In Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections.
7. 3, abstr 183, p. 88. In Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections
8. Mitsuya, H., R. Yarchoan, S. Kageyama, and S. Broder. 1990. Target therapy of human immunodeficiency virus-related disease FASEB J 5:2369-2381.
9. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
10. Patick, A., M. Hongmei, M. Markowitz, D. Ho, and S. Webber. 1995. In vitro antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of HIV-1 protease, abstr. 184, p 88. In Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections.
11. Quart, B. D., S. K. Chapman, J. Peterkin, S. Webber, and S. Oliver. 1995. Phase I safety, tolerance, pharmacokinetics and food effect studies of AG1343 - a novel HIV protease inhibitor, abstr. LB3, p. 167. In Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections.
12. Robbins, T., and J. Plattner. 1993. HIV protease inhibitors: their anti-HIV activity and potential role in treatment. J. Acquired Immune Defic. Syndr. 6: 162-170
13. Schapiro, J. M., M. A. Winters, and T. C. Merigan. 1995. First efficacy and safety results of the high dose saquinavir monotherapy trials, abstr. LB2, p. 167 in Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections.
14. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122